Many potentially useful synthetic gene networks require the expression of an engineered gene if and only if two different DNA-binding proteins exist in sufficient concentration. While some natural and engineered systems activate gene expression according to a logical AND-like behavior, they often utilize allosteric or cooperative protein-protein interactions, rendering their components unsuitable for a toolbox of modular parts for use in multiple applications. Here, we develop a quantitative model to demonstrate that a small system of interacting fusion proteins, called a protein device, can activate an engineered gene according to the Boolean AND behavior while using only modular protein domains and DNA sites. The fusion proteins are created from transactivating, DNA-binding, non-DNA binding, and protein-protein interaction domains along with the corresponding peptide ligands. Using a combined kinetic and thermodynamic model, we identify the characteristics of the molecular components and their rates of constitutive production that maximize the fidelity of AND behavior. These AND protein devices facilitate the creation of complex genetic programs and may be used to create gene therapies, biosensors and other biomedical and biotechnological applications that turn on gene expression only when multiple DNA-binding proteins are simultaneously present.
Introduction
The engineering of biological organisms to perform complex tasks is still in its infancy. There are numerous applications where the extreme genetic engineering of an organism can result in the insertion of a 'program' of incredible usefulness. Possible applications include modifying a simple bacterium to detect small quantities of chemicals or proteins, such as TNT [1] , and using gene therapy to treat a multitude of human diseases, including diabetes and cancer, by inserting the corrective DNA that produces the needed therapeutic proteins at the right times [2] . By rearranging naturally provided molecular components, such as transcription factors, mRNA hairpins, and DNA operator and promoter sites, into novel configurations, a variety of synthetic gene networks have been constructed to exhibit potentially useful dynamical behaviors [3, 4] .
Many of these gene networks, including transcriptionally or translationally regulated bistable switches [5, 6] , transcriptional [7] or metabolically coupled [8] oscillators, combined switch-oscillators [9] , cascades [10] , feedback loops [11] , population-dependent activation in bacteria [12, 13] and yeast [14] , combined metabolically coupled populationdependent activation systems [15] , and light-repressed kinaseactivated transcription factors [16] , are prototypical examples of synthetic genetic programs generating increasingly complex behaviors. Using microfluidic devices and optical microscopy, one may measure the expression dynamics of these engineered organisms on the single cell level [17] [18] [19] [20] . As more molecular components are characterized, an important goal is to identify additional gene and protein networks that exhibit new or improved behaviors.
In a variety of applications, from whole-cell biosensors [21] to tumor-invading bacteria [22] , we often would like to turn on the expression of an engineered gene if and only if multiple different environmental, regulatory or metabolic signals are present or absent. The engineered gene may encode a protein of our choice, such as a transcription factor affecting downstream genes, a therapeutic protein treating a diseased condition or an observable fluorescent protein. This behavior requires a gene and protein network to possess a dynamical behavior that mimics a logical or Boolean behavior in response to multiple inputs. Specifically, we are first interested in characterizing a gene and protein network that better mimics the two-input AND Boolean response by turning on the expression of an engineered gene if and only if two different regulatory proteins both exist at a sufficient concentration. As part of a larger synthetic network, this subnetwork would be responsible for integrating two independent signals, codified by the concentration of two different regulatory proteins, to activate a desired gene according to a pre-programmed 'AND' response.
There are many examples of biochemical and genetic processes proceeding with an approximate Boolean logic. Using mathematical modeling, the response characteristics of single and multi-enzyme systems found in common metabolic biochemical networks were shown to mimic the fundamental AND, OR, and NOT Boolean behaviors [23] . By applying the chemical partition function to study the cis-regulation of bacterial promoters, it was mathematically shown that the regulation of gene expression is also, in principle, capable of exhibiting all of the fundamental Boolean behaviors [24] . However, such regulation required the highly cooperative binding of transcription factors and the presence of DNA looping. These and other principles, derived by mathematical models, were tested in both bacterial [25, 26] and mammalian [27] cells by constructing or studying gene networks that utilize transcription factors and small molecule inducers to turn gene expression on or off according to approximate Boolean behaviors. These genetic systems are prototypical examples of how the dynamics of regulated gene expression may closely mimic useful Boolean logic.
In this paper, we propose a new type of gene and protein network, called a protein device, which transcriptionally regulates gene expression according to a multi-input Boolean behavior. Composed of modularly constructed scaffold and scaffold-binding proteins, the protein device conditionally binds to its cognate DNA sites and recruits RNA polymerase, catalyzing the initiation of transcription. We focus our current study on a protein device that activates gene expression according to the two-input AND Boolean behavior and use both deterministic and stochastic mathematical modeling to quantify its dynamical behavior. The AND protein device has a number of advantages over existing, functionally equivalent gene and protein networks, including its modular construction, rapid dynamical response, high fidelity and high scalability (discussed in section 4.1). These advantages arise from the use of some recently characterized protein domains. We briefly describe the characteristics of these newly available molecular components.
Scaffold proteins, zinc-finger proteins, and synthetic transactivators
While they sometimes possess additional activities, the purpose of a scaffold protein is to colocalize two or more other proteins to adjacent positions in space. Importantly, many scaffold proteins are fusion proteins consisting of multiple fused protein-protein interaction domains whose individual binding activities are independent from one another. This modularity between protein domains allows an organism, through recombination, deletion and insertion, to combinatorially combine different protein-protein interaction domains together to create thousands of different scaffold proteins [28] . By interacting with receptors and enzymes, these scaffold proteins are responsible for transducing the input signals an organism receives and processing them for downstream usage. The modularity of scaffold proteins has been tested by successfully replacing, inserting and swapping protein-protein interaction domains in the Ste5 and Pbs2 scaffold proteins in yeast while either maintaining their responses to high osmolarity and mating factor or rewiring their input/output relationships [29] . By fusing together natural protein-protein interaction domains into novel configurations, synthetic scaffold proteins have also been created [30] . These synthetic scaffold proteins can catalyze actin polymerization according to the OR and AND Boolean behaviors. Using similar synthetic scaffold proteins, we extend their capabilities to regulating gene expression according to Boolean logic.
Importantly, there are thousands of different proteinprotein interaction domains, roughly separated into at least 16 distinct types and each binding to one or more peptide ligands whose sequence pattern is relatively conserved [31] [32] [33] [34] [35] [36] . The types include PDZ, SH2, SH3 and WW domains and occur most frequently in eukaryotes, but some are present in bacteria. For the remainder of the paper, we abbreviate protein-protein interaction as PPI. In table 1, we present a few examples of useful PPI domains, their peptide ligands, and affinities. Recently, a database of PDZ domains and their interactions has also been created [37] . Using a combination of phage display libraries, sequence analysis, molecular dynamics, surface plasmon resonance, NMR and structural studies [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] , the binding affinities and consensus sequences of many peptide ligands towards their corresponding PPI domains have been determined. The equilibrium dissociation constant (K d ) between a PPI domain and its peptide ligand is between 0.01 and 100 µM with an average of about 10 µM. Many PPI domains bind to C or N terminally fused ligands, making them especially useful. Synthetic PPI domains have also been created using pairs of dimerization zinc fingers (DZFs) domains [48] , adding even more components to the toolbox of protein-protein interaction domains.
The second key type of component of the proposed protein device is a DNA-binding protein domain, referred to as a DBD. Previously proposed gene networks often use bacterial or phage transcription factors, including the LacI, TetR, AraC, Cro and CI ones, to activate and repress transcriptional initiation. In general, however, one may use a variety of DNA-binding proteins utilizing a number of motifs, including [51] [52] [53] . Zinc-finger type proteins also function in both bacterial and mammalian cells [54, 55] . The free energies, G, of DBDs typically vary between −6.5 and −16 kcal mol −1 and depend on the protein, the operator sequence, and the applied DNA torsional stress.
Finally, we will require a transactivating domain to contact and recruit RNA polymerase or another rate limiting subunit of the preinitiation complex, such as basal transcription factors. In Escherichia coli, fusing the α-subunit of RNA polymerase to another domain creates a fusion protein with transactivating capabilities [54, 56, 57] . Other transactivating domains include VP16, Gal4 and c-Myb, respectively originating from herpes simplex virus, yeast and humans. Synthetic transactivation domains have also been created, using acidrich peptides or polar and hydrophobic small molecules [58] .
The organization of this paper is as follows: in section 2, we describe how we fuse these molecular components together into a system of interacting fusion proteins to create the proposed AND protein device. We then detail the deterministic and stochastic versions of the kinetic and thermodynamic model describing the rate of transcriptional initiation as a function of the concentration of the input regulatory proteins. We list the necessary assumptions and define the design goals of the analysis. In section 3, we perform a sensitivity analysis of the deterministic version of the model to determine the characteristics of each molecular component that yield a higher fidelity AND protein device. We then analyze the stochastic version of the model to explore how stochasticity in the protein-protein interactions qualitatively alters the response behavior. We conclude by simulating the dynamics of the rate of transcriptional initiation in response to step changes in the regulatory inputs. In section 4, we summarize our findings, cite the advantages of the proposed protein device over existing gene networks, discuss the usage of feedback and other nonlinear regulation, and suggest additional protein devices that regulate transcription with more complex Boolean behaviors.
Molecular design and mathematical methods

The molecular diagram
The proposed AND protein device is a system of interacting fusion proteins consisting of the following domains: one transactivation domain, two PPI domains, two peptide ligands that specifically bind to their respective PPI domains, two DBDs and two non-DNA binding domains. The fusion proteins bind to an engineered minimal promoter to turn on gene expression only if both DNA-binding proteins exist in sufficient concentration. The DNA-binding proteins are the two inputs into the system, which are produced by an upstream gene. The engineered promoter may drive the expression of any desired protein, which becomes the output of the system. A diagram depicting how these domains are fused together to create the protein device is shown in figure 1 .
By fusing the two protein-protein interaction domains together with a short intervening linker sequence and by additionally fusing the transactivation domain to either the Cor N-terminus, one creates a transactivating scaffold protein (SA), which is constitutively produced. The PPI domains in the scaffold activator bind to their respective peptide ligands while the transactivation domain recruits RNA polymerase or another factor required for forming the preinitiation complex. However, the scaffold activator may not bind to DNA on its own. Instead, using its two PPI domains, it may bind to any protein which contains one of the two corresponding peptide ligands. By fusing together each of the peptide ligands with a DNA-binding domain, we create a pair of DNA-binding proteins (DBPs) which may bind to both the scaffold activator and a DNA operator site. The pair of operators are upstream of the promoter of the engineered gene, close enough to allow the transactivation domain to recruit RNA polymerase, but far enough to prevent the scaffold complex from exhibiting steric hindrance (see figure 1(c) ). If either DNA-binding protein is present, the scaffold activator may bind to one, gain a DNAbinding capability, and transactivate gene expression. This behavior is classified as the Boolean OR.
In order to obtain Boolean AND behavior, we need to inhibit the scaffold activator's transactivation ability when either of the DNA-binding proteins is absent. To do this, two competitively inhibiting proteins (CIPs) are created by The binding and unbinding of the ligands and their corresponding protein-protein interaction (PPI) domains generates eight different bound scaffold complexes, numbered C1 through C8, and the free scaffold activator, SA. The dynamics of these nonlinear interactions are described using either deterministic ordinary differential equations or as a stochastic process. The rate of transcriptional initiation is computed using an equilibrium partition function with nine different promoter configurations. (c) Four configurations contribute to transcriptional initiation, yielding the probability of finding the promoter region in a transcriptionally ready state. The rate of transcriptional initiation is calculated using this probability and the kinetic rate of initiation when in the ready state.
fusing together each of the peptide ligands with a non-DNAbinding domain. The non-DNA-binding domain is any protein domain which significantly repulses the presence of DNA, by being highly negatively charged or having strong steric hindrance to binding. The CIPs are constitutively produced and may bind to the scaffold activator, competing with the DNA-binding proteins if either one is present. The resulting protein-protein interaction network, shown in figure 1(b), produces eight different complexes along with the free scaffold activator (SA). By assuming that a scaffold activator bound to one or more CIPs loses its ability to bind to DNA, only complexes C5, C7 and C8 may bind to the key DNA operator sites and transactivate gene expression. With the DNArepulsing presence of the CIPs, the scaffold activators will now activate gene expression with a Boolean AND-like behavior. The extent to which the protein device mimics the Boolean AND behavior will depend on the production rates of each constituent protein, the binding affinities of the PPI ligands, and the binding affinities of the DBPs.
The mathematical model
Using quantitative modeling, the question we intend to answer is the following: given the wide variety of well-characterized protein-protein interaction domains, PPI-binding ligands, DNA-binding domains, and DNA operators, what are the necessary characteristics of each type of protein domain or DNA site that yields a protein device that closely mimics the Boolean AND behavior? We consider three characteristics of the molecular components: the production rate of each fusion protein, the binding affinities of the PPI domainligand interactions, and binding affinities of the DNA-binding domain-operator site interactions. By understanding how these characteristics affect the dynamics of the system, we may choose the protein domains, DNA sites, and promoters that produce the best behavior before experimentally constructing the system. However, the quantitative model cannot answer questions related to the folding and function of each protein domain or the exact DNA sequence of promoters or DNA sites; these answers require preliminary characterization of the individual modular protein domains and DNA sites in the toolbox. However, because there are a large number of possible combinations of even a small number of wellcharacterized molecular components, a priori quantitative modeling of a protein device is required to guide its experimental construction.
The mathematical model combines either a deterministic or stochastic kinetic description of the protein-protein interactions with a thermodynamic description of the protein-DNA interactions at equilibrium. Similar to our previous work [59, 60] , the kinetic model is a system of biochemical reactions containing only mass action rate laws of first and second order. The thermodynamic model uses a chemical partition function approach that has been generalized to describe the regulated rate of transcriptional initiation with a wide variety of activating and repressing mechanisms [61] . The two types of models have been combined to predict the intracellular dynamics of lambda phage infection [62, 63] . The first use of the combined model is to determine the deterministic and stochastic steady state, or long-time, response of the AND protein device at different production rates of the DNAbinding proteins, which are the regulatory inputs. We then perform a deterministic sensitivity analysis to study how the response varies when changing either the production rates of each fusion protein or the binding affinities of the proteinprotein or protein-DNA interactions. Finally, we explore the stochastic dynamical behavior in response to step changes in the regulatory inputs.
The kinetic description is a well-mixed system of biochemical reactions consisting of the binding and unbinding of each DNA-binding protein (DBP) and competitively inhibiting protein (CIP) to the scaffold activator (SA), forming a network of 13 different chemical species, including eight bound scaffold complexes, and a total of 24 unidirectional reactions following mass action kinetic rate laws (shown in figure 1(b) ). We assume that the peptide ligands each bind to their corresponding PPI domain with the same dissociation constant, K d (µM). In addition, there are five reactions describing the production of the two DBP proteins, labeled DBP 1 and DBP 2 , the SA protein and the CIP proteins. The production rates are respectively labeled r DBP1 , r DBP2 , r SA and r CIP , where we assume both CIP proteins are produced at the same rate. All of the rates have units of proteins/second (p s
−1
). For each species, there is a first order degradation reaction with a kinetic constant of 3.8508 × 10
, which approximates the continuous dilution of cytoplasmic proteins inside a cell dividing every 30 min. In the final stochastic dynamical study, we replace the continuous dilution rate with a discrete cell division event that occurs every 30 ± 5 min, according to a Gaussian distribution. We assume that the forward binding constant for each protein-protein interaction is k f = 10 6 (M s) −1 . Throughout this study, we also assume an initial bacterial volume of 1 × 10 −15 L. With increasing accuracy, the dynamics of the chemical species in the reaction network may be described using either ordinary differential equations, stochastic differential equations or Master equations [64] . We first use ordinary differential equations (ODEs) to describe the dynamics of the protein-protein interactions because it is computationally inexpensive and enables a more thorough sensitivity analysis of the model. We use Matlab functions (Mathworks) to compute the steady state solution of the system of ODEs. It is a nonlinear parameterized function, C ODEs = f (r DBP1 , r DBP2 , r SA , r CIP ), where C is the vector of concentrations of each chemical species. In section 3.2, we relax the implied continuity and determinism approximations, describe the kinetic system of reactions using the Master equation, and simulate its stochastic dynamics with Hy3S [65] , our software package that implements the Gillespie method [66] and HyJCMSS, which is a recently developed hybrid adaptive jump/continuous stochastic method [67] . We compute 10 000 independent realizations of the dynamics until steady state, which is when the probability distribution of the numbers of molecules of each species is no longer changing. The ensemble of the number of molecules of each chemical species at steady state is a (10 000 trials × 13 species) matrix function and is denoted by S ME = f (r DBP1 , r DBP2 , r SA , r CIP ), where f is now defined on a measure space. By substituting C ODEs into the chemical partition function, we obtain the macroscopic average rate of transcriptional initiation when the deterministic kinetic system of protein-protein interactions has reached steady state. By substituting S ME into the same partition function, we obtain an ensemble of rates of transcriptional initiation at steady state that accounts for the inherent fluctuations in the kinetic system of reactions. Both descriptions use the same partition function to effectively describe the rate of transcriptional initiation at chemical equilibrium as a function of the concentration of the scaffold complexes and RNA polymerase.
By using the chemical partition function instead of a kinetic description of protein-DNA interactions, we assume that the binding and unbinding of the DBPs and RNA polymerase to their respective DNA sites are at chemical equilibrium. The assumption is valid when the kinetic system of protein-protein interactions is also at steady state, but becomes an approximation otherwise. The chemical partition function consists of nine different configurations of the promoter region, each weighted by their relative Gibbs free energies. The configurations include all possible ways that complexes C5, C7 and C8 and RNA polymerase may bind to the promoter region; non-specific binding of complexes C5, C7 and C8 to genomic DNA; and the reference state. The configuration states and their total Gibbs free energies are shown in table A1. The four configurations that are defined as the transcriptional 'ready state' are shown in figure 1(c) . The individual Gibbs free energies of binding include the RNA polymerase and the minimum promoter, G basal , the two DNA-binding proteins and their corresponding operators, G D1 and G D2 , the transactivator domain and the RNA polymerase, G A , and the non-specific binding of any DNAbinding protein to genomic DNA, G NS .
We make some additional assumptions to further simplify the analysis. We choose that G D = G D1 = G D2 , the concentration of free RNA polymerase is 0.05 µM or 30 molecules per cell, and that G NS = −6.3 kcal mol −1 , which is the non-specific binding of the Lac repressor to genomic DNA [68] . We use G basal = −7 kcal mol −1 and G A = −12 kcal mol −1 so that the minimum and maximum transcription rates are realistic for a bacterial system. In the absence of any scaffold activators, the basal rate is 0.0007 transcripts s −1 and, with saturation of DNA-binding scaffold activators, the rate is 0.1 transcripts s −1
. We also implicitly assume that a scaffold complex bound to one CIP is incapable of significantly binding to DNA. This assumption may be 
0.03 µM Constant validated by measuring the G CIP between a CIP and genomic DNA, which we assume to be much larger than − G D so that
The probability of finding the promoter region in the ith configuration is then
where G tot is the sum of the individual Gibbs free energies, RT is 0.5918 kcal mol −1 , and the exponents j, k, l and m are one if the corresponding species participates in the configuration and zero otherwise. A special case is the non-specific binding of scaffold complexes to genomic DNA, which has a density of microstates per state of [C5] + [C7] + [C8]. The rate of transcriptional initiation, r TI , is then
where k init is the kinetic rate of transcriptional initiation when the promoter region is in the 'ready state'. We use a constant k init = 0.1 s −1 , assuming that the transactivating domain only recruits RNA polymerase and does not affect the closed-toopen conformational change [69] . In the end, we obtain an expression for the rate of transcriptional initiation,
, where r TI is either the average rate of transcriptional initiation for the deterministic case or an ensemble of rates for the stochastic case.
The design goals
In the following sensitivity analysis, we vary the two regulatory inputs, r DBP1 and r DBP2 , and the characteristics of the molecular components, K d , G D , r CIP and r SA , with the baseline and ranges reported in table 2. The ranges are taken from the measured protein-protein and protein-DNA binding affinities of currently available domains and the experimentally feasible production rates of proteins by using promoter and ribosome binding site sequences of varying strengths [70] . Our design goal is to create a protein device that closely mimics the AND Boolean behavior and rapidly responds to changes in the regulatory inputs. This goal involves three measurements: the false positive activation rate, which is the rate of transcriptional initiation in the absence of either DBP1 or DBP2, must be very small. The true positive activation rate, or the rate of transcriptional initiation when both DBPs are present in significant quantities, must be sufficiently large. Finally, the rate of transcriptional initiation must rapidly respond to changes in the production rates of the DBPs. Consequently, when both DBPs are suddenly produced, the 'on' response time must be short. Likewise, when production of either DBP has ceased, the 'off' response time must also be short.
We define a design failure as when the false positive activation rate is greater than twice the amount of basal transcription, when the maximum true positive activation rate is less than 0.5 transcripts s −1 , or when the AND protein device requires more than 6 cell cycles to stop gene activation once production of a DBP ceases. The first condition defines an operating range of the regulatory inputs. The operating range is the largest production rate of the two DBP proteins such that, should the production of one DBP cease, the AND protein device will not produce excessive false positive activation. When constructing a larger upstream gene network or signal transduction cascade that produces or activates the input DNAbinding proteins, the production rates of the DNA-binding proteins must not exceed the operating range. Otherwise, the output activation of the AND protein device may not be trusted to stay below the maximum false positive rate. To make these AND protein devices as useful as possible for upstream and downstream networks, both the operating range and the true positive activation rate must be maximized.
As an example, we use the baseline combination of molecular components and show the rate of transcriptional initiation at steady state when varying the regulatory inputs, r DBP1 and r DBP2 ( figure 2(a) ). To compute the operating range of the regulatory inputs, we first set r DBP2 to zero and compute the maximum value of r DBP1 that produces less than twice the basal transcription rate. We then do the same for r DBP2 . The operating range for the baseline AND protein device is the non-shaded region shown in figure 2(b) . Because we assume the K d and G D for each protein-protein and protein-DNA interaction are, respectively, the same for each DBP protein, the operating ranges will always be a square. In reality, of course, there are asymmetries in the molecular components, which will make the operating range rectangular. For the baseline case, the operating maximum is only 0.065 proteins s −1 , or 169 proteins in the cell at steady state. Limiting the upstream gene and protein network to this maximum rate of production may require further engineering. Instead, by maximizing the operating range, the same AND protein device may be used upstream of gene and protein networks with differing production rates of DNA-binding proteins. Consequently, the main question is which molecular components are needed and at what rate are they constitutively produced in order to maximize the operating range while, when both DBPs are present, retaining a high rate of transcriptional initiation.
Results
Sensitivity analysis of the deterministic model
We find that the K d of the PPI-ligand interaction biphasically affects the false positive activation rate ( figure 3(a) ). On the axes, the color scale describes the rate of false positive transcriptional activation from (blue) basal expression to (dark red) twice the basal expression when either r DBP1 or r DBP2 is zero. The operating range is the non-shaded region and denotes the allowable r DBP1 and r DBP2 that will not result in excessive false positive activation should the production of one DNA-binding protein suddenly cease.
scaffold-binding competition between CIP and DBP proteins causes the false positive activation rate to be highly sensitive to r DBP1. Small increases in r DBP1 lead to large increases in the false positive activation rate up to a maximal rate. As the K d increases, this maximal rate also increases, but peaks at a K d between 1 and 3.5 µM. Additional increases in the K d result in a decreased maximal false positive activation rate and less sensitivity to r DBP1 . At a high K d , increases in r DBP1 lead to a more linear increase in the false positive activation rate. Consequently, to minimize the false positive activation rate at larger values of r DBP , we may choose either a low ( ∼ =0.01 µM) or a relatively high ( ∼ =50 to 100 µM) K d .
Decreasing the G D of the DNA-binding proteins to a more negative value has a straightforward effect; the presence of a smaller number of complexes bound to only DBP1 or DBP2, such as C5 or C7, leads to a greater rate of transcriptional initiation ( figure 3(b) ). In order to prevent this excessive false positive activation, the individual DNA-binding domains must bind to their operator sequences with an affinity not much greater than non-specific binding ( G D ∼ = −6.5 to −7 kcal mol −1
). When both DBPs are present, however, the G from the combined protein-DNA interactions is doubled, allowing complex C8 to specifically bind to the two operators and transactivate gene expression at a much higher rate than complex C5 or C7. In this way, we use the scaffold activator to create a dimerized transcription factor whose monomers may not specifically bind to their operators alone. However, unlike natural dimerizing transcription factors, we use modular protein-protein interaction domains and not special surface interactions to achieve the desired effect.
The competitively inhibiting proteins (CIPs) are necessary to obtain an AND-like response. Without the production of the CIPs, the presence of only one DNA-binding protein will allow the scaffold activator to bind DNA and transactivate gene expression at a high enough rate to cause a design failure, even though its G D is half that of a scaffold activator bound to two DBPs ( figure 4(a) ). To prevent a design failure at a reasonably high r DBP , the CIP proteins must be constitutively produced at a relatively large rate, such as between 1 and 4 p s −1 or about 2500-10 000 proteins in the cell. The presence of so many CIPs shifts the scaffold activator's equilibrium to a more CIP-bound state and requires more DBP proteins to effectively compete for the limited number of scaffold activator binding sites. Alternatively, by using a higher affinity peptide ligand to create the CIPs and a lower affinity one to create the DBPs, one may achieve a similar effect at a lower r CIP .
Using the baseline parameters, the constitutive production rate of scaffold activators is small enough so that, at steady state, the number of total scaffold activators is few and causes CIP and DBP proteins to compete for binding sites. However, at a larger r SA , this competition decreases and results in a greater rate of false positive transcriptional activation ( figure 4(b) ). To further increase competitive binding and decrease the false positive activation rate, we may decrease r SA to about 0.01-0.02 p s −1 , or 25-50 proteins total. At these rates, almost all scaffold complexes will be bound by at least one CIP protein unless both DBP proteins are present in sufficiently numerous amounts.
In summary, a simple sensitivity analysis of the deterministic model has determined the following: the affinity between the PPI domains and their peptide ligands must either be small or relatively large or else the operating range will be too small for practical use. A small r SA and a high r CIP lead to an overall decrease in the false positive activation rate and an increase in the area of the operating range of the regulatory inputs. Finally, a weak binding interaction between the DNAbinding proteins and their operators is required. Otherwise, scaffold activators bound to only one type of DNA-binding protein, such as complexes C5 and C7, will bind DNA with enough affinity to allow transactivation to occur at excessive false positive rates.
Using these overall trends, we now choose molecular components and their constitutive production rates that result in high fidelity AND protein devices. First, a PPI domain and peptide ligand with a K d of 50 µM is selected. The baseline value for G D is retained. These relatively weak interactions are more commonly found in nature and are easier to engineer into synthetic proteins. In order to obtain a high quality AND protein device, we must respectively decrease and increase the production rate of the scaffold activators and the competitively inhibiting proteins by a factor of 2 and 5. In figure 5 , we show the resulting operating ranges and rates of transcriptional initiation when we combine two or three of the above modifications. Simultaneously decreasing r SA and increasing r CIP results in a larger operating range while retaining accessibility to near maximum rates of transcriptional initiation. Increasing the K d while either decreasing r SA or increasing r CIP results in a larger operating range, but also reduces the accessible rate of transcriptional initiation, especially at small r DBP1 and r DBP2 . Combining all three modifications results in the largest operating range and allows sufficient transcriptional initiation at medium to large r DBP1 and r DBP2 .
However, if we possess two super-binding PPI domains with a K d of 0.01 µM then we may create an even higher fidelity AND protein device. Using the baseline values for r SA and r CIP , the G D may be decreased to −7.5 kcal mol −1 without the operating range becoming too small (see figure 6 ). At these values of K d , the AND protein device has the highest fidelity by turning on the expression of a gene with extremely small amounts of both DNA-binding proteins (∼5-25 molecules) and remaining off when one DNA-binding protein is absent. This combination of molecular components is perhaps the most optimal when a switch-like mechanism is desired. If a more gradual activation of gene expression is required then the relatively high K d is preferred.
Steady-state response of the stochastic model
We study the effects of stochasticity in the protein-protein interactions by relaxing the deterministic approximation, describing the kinetic description using a Master equation, and solving for the steady-state response, which ultimately yields an ensemble of the rate of transcriptional initiation with a corresponding stationary probability distribution. The behavior of the baseline and the 'high K d ' set of molecular components are compared by computing their false and true rates of transcriptional activation at varying production rates of the DNA-binding proteins (figure 7). Our main interest is to determine how the fluctuations in the binding and unbinding of the PPI domains to their ligands affect the component requirements set forth by the design goals.
For both the baseline and high K d set of molecular components, the distribution of the false positive transcriptional initiation is roughly Gaussian with a mean equal to the deterministic average rate (figures 7(a, c) ). While the average operating range is similar to the deterministic model, the AND protein device should only rarely exceed the false positive rate of transcriptional initiation. Consequently, the desired maximum operating range of the regulatory inputs The distribution of the true positive rate of transcriptional initiation is bimodal for both sets of molecular components ( figures 7(b, d) ) and the average rate of transcriptional initiation is not the most probable one. Instead, the AND protein device fluctuates between 'low' and 'high' transcriptional activation and the amount of time spent at the low or high rates determines the average. Compared to the baseline components, an AND protein device with the high K d set of molecular components requires significantly more DNA-binding proteins to remain at the high rate of transcriptional initiation for long periods of time. However, unlike the stringent requirement on the protein device's false positive activation rate, the design goals only require that the average true positive activation rate be sufficiently large for downstream uses. Consequently, for this design goal, the stochastic behavior of the protein-protein interactions does not alter the component requirements.
Dynamics of the stochastic model
The design goals require that the AND protein device turn on and off sufficiently fast in response to changes in the regulatory inputs. To check this requirement, we compute the stochastic dynamics of the rate of transcriptional initiation and the numbers of molecules of each DNA-binding scaffold complex, which are C5, C7 and C8, while introducing multiple step changes in r DBP1 and r DBP2 to create a staggered pulse. By comparing different sets of molecular components using the low K d regime, we find that increasing r CIP and decreasing r SA leads to a reduced 'off' time, from 12 cell cycles to 4 cell cycles (see figure 8) . The 'on' time is sufficiently fast. However, even with the best set of components, the AND protein device slowly ceases activation of an engineered gene because cell division is the only utilized means of decreasing the number of bound scaffold complexes per cell. An additional mechanism of degradation or sequestration, such as targeted degradation of the DBPs, is needed to further decrease the off time. The dynamics of the DNA-binding complexes and their effect on the false and true positive rate of transcriptional initiation illustrate the competitive interplay between CIP-bound and DBP-bound scaffold complexes. Clearly, the competitively inhibiting proteins are required to create a protein device with high fidelity AND behavior.
Discussion
The proposed AND protein device is capable of quickly activating transcriptional initiation only when two DNAbinding proteins are both present. By performing a sensitivity analysis of a quantitative model, we have determined the characteristics of each fusion protein that, when combined, yield a protein device with high fidelity Boolean AND behavior. We find that the AND behavior requires the competitive binding between CIPs and DBPs. By increasing this competitiveness with either increases in r CIP or decreases in r SA or both, the false positive output is reduced. The optimal K d for the PPI domains and their peptide ligands is either very small or relatively large (∼0.01 µM or ∼50-100 µM), where the very small K d results in a switch-like behavior and the large K d results in a more gradual activation threshold. The G D between DBPs and their cognate DNA operator sites must be relatively weak and only slightly stronger than nonspecific binding. This may seem counterintuitive; however, it is common to find natural dimeric transcription factors which bind DNA sites with strong affinity, but with monomers that have negligible affinity. A straightforward approach to create moderately binding DBPs is to fuse two or three zinc finger motifs together.
Advantages of the AND protein device over other gene networks
The proposed AND protein device has significant advantages over other transcriptionally regulated, functionally equivalent gene networks. These are its modular construction, high scalability, rapid dynamical response and high fidelity. To illustrate these advantages, let us consider and compare two previously proposed gene networks that exhibit ANDlike Boolean behavior in different ways. The first one uses strong cooperative binding between two DNA-binding proteins to recruit RNA polymerase only when both DNAbinding proteins are present in sufficient concentration [24] . The two DNA-binding proteins bind weakly to their respective DNA operator sites, which are upstream of a minimal promoter ( figure 9(a) ). However, by forming a heterodimer via a strong surface interaction, the two DNA-binding proteins can stabilize their binding and recruit RNA polymerase. The second gene network is composed of two repressible genes, each repressed by a different input repressor, but both producing an additional third repressor protein. The third repressor represses the expression of a third gene. Only when both input repressor proteins are sufficiently present will the third gene express the output protein ( figure 9(b) ) [25] .
The first gene network does not have a modular construction; its DNA-binding proteins must cooperatively bind together to their respective operator sites and therefore must specifically bind to each other and no other proteins. Because it is extremely difficult to engineer protein-protein interaction surfaces into existing DNA-binding proteins, the availability of these cooperatively binding proteins is limited to naturally occurring ones, which are few in number. In addition, one of the DNA-binding proteins must also have strong surface interactions with RNA polymerase, acting as a transactivator, which increases the engineering requirements even more. As we increase the number of requirements for a desired protein, we significantly reduce the chances that we will either find a naturally occurring protein of the same type or successfully engineer additional capabilities into an existing protein.
Instead, the proposed AND protein device uses a modular approach. Each protein-protein interaction domain has a single activity, which is to bind to its peptide ligand. Each DNA-binding domain has a single capability, which is to bind to its DNA operator site. The transactivation domain is also self-contained and independently acting. By fusing together these single-activity protein domains into fusion proteins, we may increase the number of activities each fusion protein possesses without having to engineer all of these same activities into a single protein. By collecting a toolbox of well-characterized modular protein domains, we may combinatorially combine them together to create a wide variety of protein devices. It should not be surprising that modular protein domains are often amenable to forming fusion proteins; they typically require short linkers and proper translational pausing between domains to correctly fold into fully functional proteins [28] . Evolution has apparently favored a modular approach because of the number of potential combinations in combining modular protein domains into large fusion proteins with varying activities.
The next advantage of the proposed protein device is its scalability. Future engineered organisms or gene therapy insertions will need to sense, process and act on a multitude of signaling inputs. The integration of numerous signals will certainly require multiple gene and protein networks exhibiting Boolean-like behavior, each independently accepting their inputs and producing an output. As the number of input and output signals increase, the difficulty in creating additional independently acting gene and protein networks becomes important. Consequently, we need to examine the cost of engineering additional gene and protein networks that behave as an independent logic gate. The cost may be quantified in terms of both the number of molecular components and the research required in creating them. We say that an implementation of genetic Boolean logic has high scalability if we may potentially create a low cost genetic program with a large number of inputs and outputs.
For every 'instance' or independently acting copy, the first alternative gene network requires two cooperatively binding DNA-binding proteins, two corresponding DNA operator sites, and a minimal promoter driving the expression of the output protein. Likewise, the second alternative gene network requires three repressing DNA-binding proteins, at least three corresponding DNA operator sites, and a mediumstrength promoter. Excluding the RNA polymerase-promoter interactions, none of the molecular components in these instances should have significant cross-interactions with one another. Consequently, for every additional copy, the main difficulty is finding or creating either two heterodimer-forming DNA-binding proteins or three different repressor proteins. The first gene network has poor scalability because its necessary molecular components are difficult to find or create whereas the second gene network has poor scalability because it requires three repressor proteins per independently acting instance of the network.
The proposed AND protein device has good scalability, but with a high initial cost. For the first AND protein device, one scaffold activator protein, two competitively inhibiting proteins, and two DNA-binding proteins are required. However, importantly, the scaffold activator and CIPs do not have any interactions with any DNA sites and may consequently be reused numerous times within the same cell. To add another independently acting AND protein device to the system, we need only add two additional DNA-binding proteins, their respective DNA operators, and a minimal promoter driving the expression of the output protein. Again, importantly, the DNA-binding proteins in the protein device are simply the fusion between a modular DNA-binding domain and a peptide ligand. The two additional proteins are, of course, the inputs to the Boolean AND behavior and their DNA sites direct the positioning of the scaffold activator in driving expression of the output protein. Consequently, while the first AND protein device requires five fusion proteins and an engineered promoter, each additional AND protein device requires only two fusion proteins (the inputs) and an engineered promoter (the output).
The next advantages of the AND protein device are its fast dynamic response and high fidelity. Using quantitative modeling and restricting ourselves to currently available modular protein domains, we have shown the AND protein device can closely mimic the AND Boolean behavior. We have also shown that the proposed AND protein device rapidly turns on gene expression when both DNA-binding proteins are present. However, once production of either DNA-binding protein ceases, gene expression does not turn off for at least four cell divisions. The fast dynamic 'on' response of the protein device arises from the rapid proteinprotein interactions between the scaffold and scaffold-binding proteins. The slower 'off' response is due to the relatively slow degradation rate of the input DNA-binding proteins.
While the first alternative gene network should also share a similarly fast 'on' dynamic response, the second gene network does not. When both input repressor proteins are suddenly produced they will repress production of the third repressor protein. However, the third repressor protein must then sufficiently degrade or dilute to a small enough concentration to relieve repression of the third output gene. Consequently, the dynamic response of the second gene network is limited by the degradation or dilution rate of the input repressor proteins. Again, the 'off' dynamic response for both alternative gene networks is limited by the degradation or dilution rate of the input DNA-binding proteins. In addition, the 'off' dynamic response of the second alternative gene network is limited by the slow process of gene expression, which is required to produce the third repressor and repress the output gene.
Additional nonlinear control and feedback
While we have assumed that the scaffold activators and competitively inhibiting proteins are constitutively produced, one may also regulate the expression of their corresponding genes in response to other transcription factors or even another protein device. As we show in the sensitivity analysis, modifying the rates of production of the scaffold activator and CIPs has a nonlinear effect on the output. By fully repressing expression of the scaffold activator, the protein device's activation of the engineered gene is eliminated, creating a 'hard off' switch. By overexpressing one or both CIPs, one may preferentially attenuate the input signals by requiring a higher concentration of DBPs to achieve the same level of activation. In addition, by placing part of the production of the scaffold activator or competitively inhibiting proteins under control of the AND-activated engineered promoter itself, we can create a positive or negative feedback loop, respectively. All of these regulatory mechanisms are highly nonlinear and require a quantitative model to fully understand their effects.
Additional protein devices exhibiting more complex Boolean behaviors
We would like to stress the utility of using modular protein domains to construct protein devices. Using one transactivation domain, four DNA-binding domains, three protein-protein interaction domains with their corresponding peptide ligands, and three competitively inhibiting proteins, we can create protein devices that activate or repress transcriptional initiation with a variety of compound Boolean behaviors, including OR-AND, AND-AND, and NOT-AND with 2, 3 or 4 regulatory inputs. We may also use long range interactions to simultaneously bind to distant DNA operators (see figure 10 for a non-exhaustive list of example protein devices). It is important to note that a single scaffold complex can integrate numerous input signals together to either conditionally activate or repress transcriptional initiation according to a pre-programmed Boolean-like response. In addition, by reusing the scaffold activators or repressors, these protein devices have the same scalability as the AND protein devices. By connecting these protein devices of varying Boolean behaviors in different configurations, one may generate a staggering number of complex dynamical behaviors. Quantitative modeling will be necessary to determine which of these dynamical behaviors are most useful to future applications.
Conclusion and outlook
Future applications, including living biosensors and gene therapies, will require complex regulatory mechanisms to ensure gene expression of the right proteins at the right times. The gene expression must also turn on and off in response to multiple environmental, regulatory and metabolic inputs. Because of their breadth of function and modular design, systems of interacting fusion proteins, called protein devices, are useful additions to the synthetic biologist's repertoire and enable the 'programming' of gene expression with a set of responsive Boolean instructions. We anticipate that characterization of modular protein domains, especially protein-protein interaction and DNA-binding domains, will rapidly progress. Because of the staggering number of potential combinations, quantitative modeling will be a useful tool in deciding how to best construct a protein device to produce a desired Boolean behavior. Quantitative modeling will also be useful in determining how to best link together multiple protein devices to program an organism with a complicated multi-input, multi-output biological program. set the volume to 1.0 × 10 −15 L, the number of independent trials to 10 000, the initial conditions to appropriate (but ultimately irrelevant) values, and a sufficiently long end time. The GUI then creates a NetCDF data file. The simulation algorithm (whose method and accuracy is described in [65] ) reads the input data and places 10 000 independent trials of the stochastic dynamics of the reaction network back into the data file. The solution data is then read into Matlab (Mathworks). The probability distribution of the number of molecules of each chemical species is computed. For every simulation, we confirm that the joint probability distribution at the end time is the steady-state distribution by computing the rate of change of the probability distribution and confirming that it is near zero. At the end, we obtain a steady-state ensemble of the number of molecules of each chemical species, S ME (a 10 000 × 13 matrix), which is a function of the model parameters.
The second part of the quantitative model is a chemical partition function describing the protein-DNA interactions and the rate of transcriptional initiation. The partition function describes all possible configurations of the system and uses the energies of each configuration to determine its equilibrium probability. We use the partition function because (a) the number of configurations of bound and unbound DNA sites is relatively small, (b) approximating the concentration of single DNA sites as a continuous function is very invalid, (c) the binding and unbinding of DNA-binding proteins to DNA sites is a stochastic process, and (d) the computational cost of simulating it as a stochastic process can be very high and so we assume the protein-DNA dynamics are at chemical equilibrium. The number of configurations and their free energies are shown in table A1. The values of the free energies are described in the main text. The probability of finding the system at any particular configuration, as a function of the concentration of C5, C7 and C8, and RNA polymerase, is shown in equation (1) . Shown in equation (2), the rate of transcriptional initiation is the sum of the probabilities of finding the promoter in a transcriptionally ready state multiplied by the kinetic rate of transcriptional initiation, which is assumed to be k init = 0.1 s . Equation (2) assumes that the transactivator domain only recruits RNA polymerase to the promoter and that transcriptional initiation is rate limited by RNA polymerase binding. Equations (1) and (2) depend on the free energies of each configuration. Each of these energies is kept constant throughout the entire analysis, except for one model parameter: the free energy, G d , between each DNA-binding protein and its corresponding DNA operator.
In the deterministic version of the kinetic model, we substitute the steady-state solution C into equations (1) and (2) to yield r TI , which is a function of all of the model parameters. In the stochastic version of the kinetic model, we convert the number of molecules of each chemical species in the ensemble S ME into concentrations and substitute it into the partition function. When varying the model parameters, we resolve the steady-state solutions of either the ordinary differential equations or the Master equation and resubstitute it into the partition function. From this, we obtain the rate of transcriptional initiation, r TI , with any set of values of the model parameters.
